Abstract:OBJECTIVE:To assess the estrogen and progestin's effect on protein expression of metastasis repression gene nm23-H1 via regulation of phosphorylation signaling in epithelial ovarian cancer cell line ES-2.METHODS:Ovarian clear cell adenocarcinom cell line ES-2 was treated by different doses of 17beta-estradiol (estrogen), medroxyprogestogen (progestin) and dimethyl sulfoxide (control group), and then the following experiments were conducted. (1) Change of the cell migration capacity after treatment with estrogen and progestin for 24 and 48 hours was measured by in vitro wound healing assay. (2) Transwell experiments were used to detect the ability of cell invasion, which was also used to inhibit the phosphorylation of protein kinase B (AKT) pathway with estrogen and progestin. (3) Change of nm23-H1, AKT and phosphorylated protein kinase B (pAKT) protein level of ES-2 cells after treated with estrogen and progestin was detected by western blot. (4) Cells were transfected with the small interfering RNA (siRNA) expression vector targeting AKT. The efficiency of cells transfected was calculated according to the number of cells with green fluorescent produced by cells transfected. Change of nm23-H1 expression was assessed.RESULTS:ES-2 cells treated with estrogen, progestin or vehicle all migrated into the wound surface after 24 and 48 hours. The migration of the cells treated with estrogen was (1.39 +/- 0.08) mm, significantly elevated (P = 0.029), and that of the cells treated with progestin was (1.96 +/- 0.07) mm, significantly decreased compared with cells treated with vehicle (P = 0.014). The cells were cultured in transwell after 24 hours. The invasion of the cells treated with estrogen was 119 +/- 13, significantly elevated (P = 0.015), and that of the cells treated with progestin was 78 +/- 8, significantly decreased compared with cells treated with vehicle (P = 0.006). Western blot results showed that 17beta-estradiol decreased nm23-H1 expression, and both effects were dose and time dependent (P = 0.020, P = 0.001). Progestin increased nm23-H1 expression in ES-2 cells, and both effects were dose and time dependent (P = 0.003, P = 0.002). 17beta-Estradiol elevated the expression of pAKT, which was also dose and time dependent (P = 0.001, P = 0.007), while progestin repressed pAKT expression which was also dose and time dependent (P = 0.012, P = 0.039). When cells were transfected with the siRNA expression vector targeting AKT, the effects of estrogen and progestin on nm23-H1 expression were both attenuated.CONCLUSIONS:Estrogen downregulates the expression of nm23-H1 via activation of the phosphorylation signaling, thus participated in the regulation of invasion and metastasis of epithelial ovarian cancer cells. Progestin upregulates the expression of nm23-H1, and might repress invasion and metastasis of tumor cells.

Estrogen Stimulates the Invasion of Ovarian Cancer Cells Via Activation of the PI3K/AKT Pathway and Regulation of Its Downstream Targets E-cadherin and Α-Actinin-4

Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathway.

Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Lysine-specific Demethylase 1 Mediates Epidermal Growth Factor Signaling to Promote Cell Migration in Ovarian Cancer Cells

Estrogen And Progestin Regulate Metastasis Through The Pi3k/Akt Pathway In Human Ovarian Cancer

Estrogen And Progestin Regulate Hif-1 Alpha Expression In Ovarian Cancer Cell Lines Via The Activation Of Akt Signaling Transduction Pathway

The mechanism of estrogen regulation of metastasis related protein osteopontin(OPN) in epithelial ovarian cancer

Oestrogen Receptor Alpha Mediates 17 Beta-Estradiol Enhancement Of Ovarian Cancer Cell Motility Through Up-Regulation Of Survivin Expression

17Β-Estradiol Activates PI3K/Akt Signaling Pathway by Estrogen Receptor (Er)-Dependent and ER-independent Mechanisms in Endometrial Cancer Cells

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

17Β-Oestradiol Activates Proteolysis and Increases Invasion Through Phosphatidylinositol 3-Kinase Pathway in Human Cervical Cancer Cells.

Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3

Estrogen-independent Effects of ER-α36 in ER-negative Breast Cancer

Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN

Effects of Oestrogen on Long Noncoding RNA Expression in Oestrogen Receptor Alpha-Positive Ovarian Cancer Cells

Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer

Echinacoside inhibits the proliferation, migration, invasion and angiogenesis of ovarian cancer cells through PI3K/AKT pathway

Activation of the Pi3k/Akt Pathway Mediates Fsh-Stimulated Vegf Expression in Ovarian Serous Cystadenocarcinoma

Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis

[Influence of Estrogen and Progestin on Nm23-H1 Expression in Epithelial Ovarian Cancer Cell Lines Via Activation of Phosphorylation Signaling].